![](data:image/svg+xml;base64,PD94bWwgdmVyc2lvbj0iMS4wIiBlbmNvZGluZz0iVVRGLTgiPz4KPHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHhtbG5zOnhsaW5rPSJodHRwOi8vd3d3LnczLm9yZy8xOTk5L3hsaW5rIiB3aWR0aD0iMTQ4Ny41cHQiIGhlaWdodD0iMTkyNXB0IiB2aWV3Qm94PSIwIDAgMTQ4Ny41IDE5MjUiIHZlcnNpb249IjEuMiI+CjxnIGlkPSJzdXJmYWNlOSI+CjwvZz4KPC9zdmc+Cg==)
chronic illnesses and pregnant women may once again be subjected
to the annual and lifetime limits on the amount of medical
benefits their health insurance pays; and
WHEREAS, Young adults have the highest uninsured rate of any
age group at 30%; and
WHEREAS, Young adults have the lowest rate of access to
employer-based health insurance; and
WHEREAS, One-in-six young adults have a serious or chronic
illness, such as cancer or diabetes; and
WHEREAS, The act permits young adults to remain on their
parent's health insurance until they reach 26 years of age; and
WHEREAS, If this provision is repealed, it is estimated that
6 million young adults in the nation, including 89,000 young
adults in this Commonwealth, are at risk of becoming uninsured;
and
WHEREAS, Prior to the passage of the act, individuals seeking
care by means of a clinical trial were responsible for paying
out of pocket for ancillary costs associated with the trial; and
WHEREAS, These costs could include CAT scans, blood work, X-
Rays, MRIs and other expensive tests and procedures; and
WHEREAS, Costs associated with these tests and procedures are
estimated at $30,000 or more; and
WHEREAS, The act ensures that any qualified individual
participating in a clinical trial will not have their benefits
limited or denied in respect to routine costs associated with
participation in a clinical trial; and
WHEREAS, If these important protections are repealed,
millions of Pennsylvanians, including the most vulnerable
members of our society, will be adversely affected; therefore be
it
20170HR0091PN0551 - 3 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30